SNES - SenesTech, Inc.
Previous close
3.28
0 0%
Share volume: 1
Last Updated: Fri 27 Dec 2024 08:26:46 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$3.28
0.00
0.00%
Fundamental analysis
40%
Profitability
25%
Dept financing
7%
Liquidity
75%
Performance
55%
Performance
5 Days
13.41%
1 Month
38.50%
3 Months
24.70%
6 Months
449.12%
1 Year
262.90%
2 Year
-90.68%
Key data
Stock price
$3.28
DAY RANGE
$3.28 - $3.28
52 WEEK RANGE
$0.51 - $5.80
52 WEEK CHANGE
$146.46
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO: Joel Fruendt
Region: US
Website: senestech.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: senestech.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
SenesTech, Inc. develops technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and headquartered in Phoenix, Arizona.
Recent news